Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Scandius BioMedical to Market TriTis Tibial Fixation System - Medical Product Outsourcing
Supplier News

Scandius BioMedical to Market TriTis Tibial Fixation System

LITTLETON, Mass., Feb. 9 (UPI) — Scandius BioMedical said Thursday it has been approved to market the TriTis Tibial Fixation System for soft-tissue rebuilding. The company said its system has been used successfully to reconstruct the leg’s anterior cruciate ligament, which it said is the most common sports-related orthopedic joint injury. Scandius’s technology combines a cleat for tissue compression in the tunnel, a fixation screw to anchor the device and a fixation washer to prevent graft slippage. The system is specifically designed for procedures involving the tibia, where bone quality is softer, making it harder to hold a soft-tissue graft in place. “Current tibial fixation products often force surgeons to make a choice between intra-tunnel compression to achieve aperture fixation or cortical fixation to achieve strength,” said Mark Johanson, president and chief executive officer of Scandius. “We believe that TriTis will offer both, providing surgeons with the optimal clinical outcome they desire.”

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters